Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Hair straightening can damage hair and pose health risks, including exposure to carcinogens and hair loss.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Scalp cooling helps prevent hair loss and improves quality of life during chemotherapy.

Immune cells affect hair growth and could lead to new hair loss treatments.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Hair graying is caused by the loss of pigment cells due to poor maintenance of stem cells in the hair follicle.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Improving human hair follicle models is crucial for better hair loss treatments.

Using too much minoxidil foam can cause a rare movement disorder with facial twitching, but symptoms go away when the correct dose is used.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

A 4-year-old girl with hair loss was diagnosed with early-onset trichotillomania and improved with behavioral interventions.

Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.

A mouse model was created to study hair loss similar to humans.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

UTX is important for skin health and its loss can lead to skin issues, especially in females.

Light can activate hair growth through a pathway from the eyes to hair follicles.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

GPC1 is important for blood vessel growth in hair follicles and could help treat hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Combining RU58841 and minoxidil significantly increases hair growth.

Hair follicle bulge cells are important for hair survival and help heal the skin after injury, which might be relevant for understanding hidradenitis suppurativa.